Cytochrome c release is required for phosphatidylserine peroxidation during Fas-triggered apoptosis in lung epithelial A549 cells.
Oxidation of phosphatidylserine (PtdSer) has been shown to play a pivotal role in signaling during cell apoptosis and subsequent recognition of apoptotic cells by phagocytes. However, the redox catalytic mechanisms involved in selective PtdSer oxidation during apoptosis remain poorly understood. Here we employed anti-Fas antibody CH-11-treated A549 cells as a physiologically relevant model to investigate the involvement of PtdSer oxidation and its potential mechanism during apoptosis. We demonstrated that ligation of CH-11 with its cognate receptor initiated execution of apoptotic program in interferon gamma-pretreated A549 cells as evidenced by activation of caspase and DNA fragmentation. A significant increase of cytochrome c (cyt c) content in the cytosol as early as 2 h after CH-11 exposure was detected indicating that Fas-induced apoptosis in A549 cells proceeds via extrinsic type II pathway and includes mitochondrial signaling. PtdSer was selectively oxidized 3 h after anti-Fas triggering while two more abundant phospholipids--phosphatidylcholine (PtdCho) and phosphatidylethanolamine (PtdEtn)--and the major intracellular antioxidant, glutathione, remained nonoxidized. A pan-caspase inhibitor, z-VAD, fully blocked cyt c release and oxidation of PtdSer in Fas-treated A549 cells. On the other hand, z-DQMD, a caspase-3 inhibitor, completely inhibited caspase-3 activity but did not fully block caspase-8 activation and release of cyt c. Importantly, z-DQMD failed to protect PtdSer from oxidation. In addition, in a model system, we demonstrated that peroxidase activity of cyt c was greatly enhanced in the presence of dioleoylphosphatidylserine containing liposomes by monitoring oxidation of 2',7'-dichlorodihydrofluorescein to 2',7'-dichlorofluorescein. We further showed that peroxidase activity of cyt c catalyzed oxidation of 1-palmitoyl-2-arachidonoyl-3-glycero-phosphoserine using a newly developed HPLC assay. MS analysis of 1-palmitoyl-2-arachidonoyl-3-glycero-phosphoserine revealed that in addition to its mono- and dihydroperoxides, several different PtdSer oxidation products can be formed. Overall, we concluded that cyt c acts as a catalyst of PtdSer oxidation during Fas-triggered A549 cell apoptosis.
Jiang
Jianfei
J
Department of Environmental and Occupational Health, Center for Free Radical and Antioxidant Health, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA.
Kini
Vidisha
V
Belikova
Natalia
N
Serinkan
Behice F
BF
Borisenko
Grigory G
GG
Tyurina
Yulia Y
YY
Tyurin
Vladimir A
VA
Kagan
Valerian E
VE
D000906:Antibodies / Q000276:immunology; D017209:Apoptosis; D053181:Caspase 8; D020169:Caspases / Q000378:metabolism; D002384:Catalysis; D045744:Cell Line, Tumor; D045304:Cytochromes c / Q000378:metabolism*; D004847:Epithelial Cells / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology; D015227:Lipid Peroxidation; D008168:Lung / Q000166:cytology; D013058:Mass Spectrometry; D010718:Phosphatidylserines / Q000378:metabolism*; D011480:Protease Inhibitors / Q000494:pharmacology; D019014:fas Receptor / Q000378:metabolism*
D000906:Antibodies; D010718:Phosphatidylserines; D011480:Protease Inhibitors; D019014:fas Receptor; D007371:Interferon-gamma; D045304:Cytochromes c; C505530:CASP8 protein, human; D053181:Caspase 8; D020169:Caspases
Biochemistry. 1998 May 5;37(18):6402-9
9572857
Blood. 2001 Nov 1;98(9):2603-14
11675328
FEBS Lett. 1999 Nov 26;462(1-2):192-8
10580118
EMBO J. 1983;2(6):907-13
16453458
J Immunol. 2002 Jul 1;169(1):487-99
12077280
Science. 1993 Oct 29;262(5134):689-95
7901908
J Biol Chem. 1986 Mar 15;261(8):3846-56
3005302
Eur Respir J. 2001 Feb;17(2):180-9
11334117
J Neurosci Res. 1998 Feb 1;51(3):293-308
9486765
J Clin Pathol. 2001 Feb;54(2):132-8
11215282
Mol Cell. 2004 May 7;14(3):277-87
15125832
EMBO J. 1998 Mar 16;17(6):1675-87
9501089
Biochemistry. 1997 Oct 21;36(42):13122-32
9335575
Protein Sci. 2000 Jun;9(6):1194-202
10892811
Anal Biochem. 1970 Jul;36(1):225-6
5482631
Am J Physiol. 1997 Feb;272(2 Pt 1):C675-84
9124312
J Invest Dermatol. 2002 Jun;118(6):1008-18
12060396
Am J Physiol. 1998 Dec;275(6 Pt 1):L1192-9
9843857
Biochemistry. 1998 Sep 29;37(39):13781-90
9753467
J Invest Dermatol. 1991 Jul;97(1):115-9
1647419
Transplant Proc. 1997 Feb-Mar;29(1-2):1532-5
9123414
Cell. 1991 Jul 26;66(2):233-43
1713127
Free Radic Biol Med. 2004 Dec 15;37(12):1963-85
15544916
Chem Res Toxicol. 1992 Mar-Apr;5(2):227-31
1322737
Neuron. 1988 Oct;1(8):623-34
2908446
Biochem Biophys Res Commun. 2001 Mar 23;282(1):329-33
11264011
Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11796-800
8524851
Scand J Clin Lab Invest. 1984 Sep;44(5):439-46
6484484
Biochim Biophys Acta. 1996 Sep 4;1283(2):127-40
8809092
Free Radic Biol Med. 2003 Oct 1;35(7):814-25
14583346
J Biol Chem. 1989 Mar 5;264(7):3988-97
2537300
FEBS Lett. 1998 Feb 27;423(3):275-80
9515723
Mol Cell Biochem. 2002 May-Jun;234-235(1-2):125-33
12162425
FEBS Lett. 2000 Jul 14;477(1-2):1-7
10899301
J Biol Chem. 1957 May;226(1):497-509
13428781
Biochemistry. 1990 Mar 27;29(12):2930-8
2337575
Chem Res Toxicol. 2004 May;17(5):685-96
15144226
Biochem J. 1998 Jan 1;329 ( Pt 1):95-9
9405280
Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):737-44
11254533
Biochemistry. 2002 Feb 12;41(6):2075-88
11827555
Eur Respir J. 1990 Jan;3(1):19-23
2107097
Eur J Biochem. 1992 Oct 1;209(1):267-73
1396703
Am J Physiol Lung Cell Mol Physiol. 2003 Jul;285(1):L1-17
12788785
EMBO J. 1997 Aug 1;16(15):4639-49
9303308
Am J Physiol. 1997 Nov;273(5 Pt 1):L921-9
9374718
Methods Mol Biol. 1998;108:71-87
9921517
Nature. 2002 Sep 26;419(6905):367-74
12353028
FEBS Lett. 1998 Mar 27;425(2):209-12
9559649